Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 4, 2004, Pages 761-766

  De Sarro, Giovambattista ^a   Russo, Emilio ^a   Ferreri, Guido ^a   Giuseppe, Bruzzese ^a   Flocco, Maria Antonietta ^a   Di Paola, Eugenio Donato ^a   De Sarro, Angela ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Aminobutyric acid; Convulsants; Epilepsy; Excitatory amino acid; Interleukin 6; Seizures

Indexed keywords

4 AMINOPYRIDINE; 4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; BICUCULLINE; CONVULSANT AGENT; INTERLEUKIN 6; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; PENTETRAZOLE; PICROTOXIN; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; STIMULUS RESPONSE; STRAIN DIFFERENCE; TONIC SEIZURE;

ANIMALS; CONVULSANTS; DISEASE SUSCEPTIBILITY; EXCITATORY AMINO ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; SEIZURES;

ANIMALIA;

EID: 1942423710     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.01.012     Document Type: Article

References (40)

1. Akaneya Y., Takahashi M., Hatanaka H. Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp. Neurol. 136:1995;44-52.
2. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78. [Review].
3. Ali C., Nicole O., Docagne F., Lesne S., MacKenzie E.T., Nouvelot A.et al. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab. 20:2000;956-966.
4. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 29(202):1995;17-20.
5. Carlson N.G., Wieggel W.A., Chen J., Bacchi A., Rogers S.W., Gahring L.C. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6 and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163:1999;3963-3968.
6. Chai Z., Gatti S., Toniatti C., Poli V., Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J. Exp. Med. 183:1996;311-316.
7. Chapman A.G., De Sarro G.B., Premachandra M., Meldrum B.S. Bidirectional effects of beta-carbolines in reflex epilepsy. Brain Res. Bull. 19:1987;337-346.
8. De Bock F., Dornand J., Rondouin G. Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport. 7:1996;1125-1129.
9. De Sarro G.B., Meldrum B.S., Nisticò G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmacol. 93:1988;247-256.
10. Engstrom F.L., Woodbury D.M. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia. 29:1988;389-395.
11. 2+ channel physiology and disease etiology. Cell. Mol. Neurobiol. 22:2002;103-120.
12. Gadient R.A., Otten U. Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci. Lett. 153:1993;13-16.
13. Gadient R.A., Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 637:1994;10-14.
14. Gadient R.A., Otten U.H. Interleukin-6 (IL-6) a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52:1997;379-390.
15. Gidal B.E., Reiss W.G., Liao J.S., Pitterle M.E. Changes in IL-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokinetics. Ann. Pharmacother. 30:1996;545-546.
16. Gijbels K., Brocke S., Abrams J.S., Steinman L. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:1995;795-805.
17. Go T., Nakamura K. Frequent seizures with elevated IL-6 at the eruptive stage of exanthema subitum. Eur. J. Pediatr. Neurol. 6:2002;221-223.
18. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
19. Higuchi M., Ito T., Imai Y., Iwaki T., Hattori M., Kohsaka S.et al. Expression of the alpha2-macroglobulin-encoding gene in rat brain and cultured astrocytes. Gene. 141:1994;155-162.
20. Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33:1990;644-649.
21. Hopkins S., Rothwell N. Cytokines and the nervous system: I. Expression and recognition. Trends Neurosci. 18:1995;83-88.
22. Ichiyama T., Nishikawa M., Yoshitomi T., Hayashi T., Furukawa S. Tumor necrosis factor-alpha IL-1 beta, and IL-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/ encephalopathy. Neurology. 50:1998;407-411.
23. Ichiyama T., Okada K., Lipton J.M., Matsubara T., Hayashi T., Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 857:2000;246-251.
24. Kimura M., Tasaka M., Sejima H., Takusa Y., Ichiyama T., Yamaguchi S. Hemiconvulsion-hemiplegia syndrome and elevated IL-6: case report. J. Child Neurol. 17:2002;705-707.
25. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
26. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598.
27. Noebels J.L. A single gene error of noradrenergic axon growth synchronizes central neurones. Nature. 310:1984;409-411.
28. Peltola J., Hurme M., Miettinen A., Keranen T. Elevated levels of interleukin-6 occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31:1998;129-133.
29. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M.et al. Interleukin-6 and interleukin-1 receptors antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 41:2000;205-211.
30. Peltola J., Laaksonen J., Haapala A.M., Hurme M., Rainesalo S., Kerano T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure. 11:2002;44-46.
31. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H.et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1994;1189-1196.
32. Schobitz B., de Kloet E.R., Sutanto W., Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1993;1426-1435.
33. Seyfried T.N., Glaser G.H. A review of mouse mutants as genetic models of epilepsy. Epilepsia. 26:1985;143-150.
34. Straussberg R., Amir J., Harel L., Punsky I., Bessler H. Pro- and anti-inflammatory cytokines in children with febrile convulsions. Pediatr. Neurol. 24:2001;49-53.
35. Swinyard E.A., Woodhead J.M. Experimental detection, quantification and evaluation of anticonvulsants. Woodbury D.M., Penry J.K., Pippinger C.E. Antipileptic drugs. 1982;111-126 Raven Press, New York.
36. Takumi Y., Matsubara A., Rinvik E., Ottersen O.P. The arrangement of glutamate receptors in excitatory synapses. Ann. N. Y. Acad. Sci. 30(868):1999;474-482.
37. Toulmond S., Vige X., Fage D., Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144:1992;49-52.
38. Virta M., Hurme M., Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines with febrile seizures. Epilepsia. 43:2002;920-923.
39. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180.
40. Yamaguchi S., Rogawski M.A. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 11:1992;9-16.